Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.
about
Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer diseaseNeuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathwaysHIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial HyperpolarizationCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationAnalyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesbeta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with agingAccumulation of amyloid beta-protein in the low-density membrane domain accurately reflects the extent of beta-amyloid deposition in the brainClusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's diseaseThe autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient miceDrugs for Alzheimer's diseaseAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 miceSelective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analysesRegulation of amyloid precursor protein processing by the Beclin 1 complexAPP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesisTransgenic models of Alzheimer's disease: learning from animalsMolecular mechanisms of neurodegeneration in Alzheimer's disease.beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.Preclinical non-human models to combat dementiaDespite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicityTransgenic mouse model for the formation of Hirano bodies.Kinesin molecular motors: transport pathways, receptors, and human disease.Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice.Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseNeuritin can normalize neural deficits of Alzheimer's disease.Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's diseaseChanges in the ageing brain in health and disease.Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice.Differential roles of Aβ processing in hypoxia-induced axonal damageNeurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function.Curcumin protects against intracellular amyloid toxicity in rat primary neurons.Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology.Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging.
P2860
Q24317439-9A0E4FC0-4F31-4D56-9B42-CEF8DB27AAA8Q26779424-9F2E73E0-ACBF-4F01-8A2B-EC9FD02C8C42Q27487322-9766F3A6-52D9-4879-9C41-E79588995A51Q28087030-9E73ED5C-5C70-4EDF-A0E7-906D69E107E1Q28087158-14270D39-2CD9-4F4D-866D-585D49CB4C57Q28345657-161D55CF-3F57-4556-A6A3-6EF2F57DE25DQ28366524-B8C6FD76-71BE-4DB4-B9FA-8460D358C2BEQ28504767-C847E809-18CE-4930-B904-6C5C5F8E293FQ28591283-49969E73-8868-4A52-BC78-38BA3221AD6EQ28592196-8CDDB675-A167-4442-AAEF-79959D22D10AQ28728362-A9A2C111-B5A3-4694-9368-E85C1F033853Q30455082-578AE8A9-2ADA-435D-B4C5-0EB37F5CCAFDQ30506148-811F5C11-33C1-46BC-A273-EDCD80D17EFEQ30635401-A124E663-CFCB-4E40-8728-A940420DE339Q33202467-C822F6F5-33AA-44FD-99E3-39435AC1AFFEQ33608732-3002CCD7-780F-4BFA-8898-099A21CD6980Q33759956-179FC436-9B0E-4C27-9350-88C4F28B6708Q33844718-1FF8F6C3-F7B4-49EF-ABBC-E7AFE3CD61EBQ33871297-FF68E525-1C61-4405-B914-F9DFF5B0CC2FQ33947152-EB1C5E47-DCC9-4771-8B82-40969D3D3240Q33979812-99B9B942-C882-4F27-B98B-A86699B19C08Q34012473-D6B47C50-EC7E-44B0-B700-92667791CBCFQ34042057-245AB112-1131-4EE3-A6CD-5EE0F70EEDA8Q34287420-A024F93C-6DD0-49C2-BFC5-C8D06451CE90Q34459388-0E265749-C7BD-43A3-9280-38DA25B7BE09Q34625154-92C92489-501B-4999-8051-D0986EF1F958Q34627188-8D825BB6-2A1C-4750-9A9C-7BD9BA6E9C8BQ34662239-42FF2B38-7F8D-441E-8F5E-6CB505A98410Q34961009-40260C2F-28C6-471C-9D20-38B04E44893DQ35016226-E9A06527-DE76-49F8-8698-6A840E5CEB79Q35070000-4835C38A-A67B-4683-9CEF-1F4E9C864831Q35084110-B73D7648-50E4-4B7F-8B8A-B4FFA3EFFD34Q35211845-1C35B1B9-CF28-459E-BB5E-9F8BF1B4ED52Q35246412-8DBA4B26-B538-4620-97B7-6DD845273AFEQ35430964-03D79142-A357-4170-9450-A91CCA0B23CFQ35472528-251DD472-2B43-493A-8D42-0B088E1D24ACQ35565575-C0E101C4-51F3-40F2-BD4F-9281B1E1E59AQ35738539-A41FD83B-D5E2-4FBF-90DA-174070B14AFDQ35747757-7C614101-9735-4AF9-A042-5BD06FFCF984Q35754595-E075C210-6CD8-4D05-8410-C8B61057B04C
P2860
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@ast
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@en
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@nl
type
label
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@ast
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@en
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@nl
prefLabel
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@ast
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@en
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@nl
P2093
P921
P1476
Comparison of neurodegenerativ ...... otein and Alzheimer's disease.
@en
P2093
P304
P356
10.1523/JNEUROSCI.16-18-05795.1996
P407
P577
1996-09-01T00:00:00Z